Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Symic Biomedical reports treatment of first patient with SB-061

June 14, 2016

Eisai presents latest phase I/II data for E-6011 in rheumatoid arthritis and Crohn's disease

June 14, 2016

GS-9876: preclinical data

June 14, 2016

Biosimilar rituximab GP-2013 shows bioequivalence

June 14, 2016

FDA will review biosimilar application for Amgen's adalimumab

June 14, 2016

Preliminary phase I data for milatuzumab

June 13, 2016

Crispr Therapeutics and Anagenesis Biotechnologies enter collaboration for P2MC technology

June 9, 2016

Pfizer announces phase II results of tofacitinib citrate

June 8, 2016

Can-Fite reaches agreement with EMA for piclidenoson phase III trial

June 2, 2016

Anika Therapeutics announces European commercial launch of Cingal

June 2, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...